Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
about
Effects of communicating DNA-based disease risk estimates on risk-reducing behavioursThe MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicineAPOE-4 genotype and neurophysiological vulnerability to Alzheimer's and cognitive aging.Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.Debating clinical utilityImpact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.Genetic testing for Alzheimer's and long-term care insurance.GINA, genism, and civil rightsThe Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.Estimating and disclosing the risk of developing Alzheimer's disease: challenges, controversies and future directionsImplementation and utilization of genetic testing in personalized medicine.Should we disclose amyloid imaging results to cognitively normal individuals?The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL StudyEmerging issues in public health genomics.The ghost in our genes: legal and ethical implications of epigenetics.Associations between self-referral and health behavior responses to genetic risk information.Returning individual research results: development of a cancer genetics education and risk communication protocolChanges to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease riskUsing Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomicsDifferences between African American and White research volunteers in their attitudes, beliefs and knowledge regarding genetic testing for Alzheimer's diseaseWillingness to pay for genetic testing for Alzheimer's disease: a measure of personal utilityGenetic counseling and testing for Alzheimer disease: joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic CounselorsEthics and neuropsychiatric genetics: a review of major issues.Defining the spectrum of genome policy.Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.Health insurance and the Genetic Information Nondiscrimination Act of 2008: implications for public health policy and practice.The future of direct-to-consumer clinical genetic tests.Genetic susceptibility testing for neurodegenerative diseases: ethical and practice issues.Communicating genetic risk information for common disorders in the era of genomic medicine.Ethical issues of predictive genetic testing for diabetes.Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.Desire for predictive testing for Alzheimer's disease and impact on advance care planning: a cross-sectional study.Engagement and communication among participants in the ClinSeq Genomic Sequencing Study.Would you want to know? Public attitudes on early diagnostic testing for Alzheimer's disease.The right not to know: the case of psychiatric disorders.Planning Ahead or Living a Day at a Time? A Family History of AD and Retirement Planning.Are guidelines needed for the diagnosis and management of incipient Alzheimer's disease and mild cognitive impairment?Expert consensus document: Mind the gaps—advancing research into short-term and long-term neuropsychological outcomes of youth sports-related concussions.Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies.
P2860
Q24234616-40E43840-08B2-4B5E-B9D6-0CF50068EDACQ30585056-E2A1AF72-9755-49D9-B061-A13CE5F35DDBQ33423191-D46A70D6-F304-4A60-B986-002E53426494Q33572491-1489489E-508D-43EB-A77C-8EF4654853E2Q33832923-C0B46E1F-998C-409B-9BCF-C60BE65098F0Q34032455-A2F113DE-FF94-4702-AA4C-2703D83FFD53Q34097151-333DB2E8-F1AC-427F-A144-DF9B0327E33BQ34100723-81A4022E-5D30-4E0C-B780-5A0B0D2B9A2FQ34113976-56390541-FEC2-453C-A22F-564EFF7EE250Q34135724-61DB81C4-DB51-4188-9F2C-B5537A374D60Q34147916-0343E490-CFDE-4012-923E-533DE58406A5Q34286140-E8A0BF83-A701-44E7-8017-EB7AC9F383E1Q34332529-1BB586D6-18BA-4487-9C8F-8CBB786F09B5Q34496940-85591190-6AF1-4402-A1B5-0F88747606C9Q34555647-DC99160F-B868-4668-BE24-5FC0EBEB72ABQ35030090-A4757DC4-2D59-4D4C-BA8A-962A7F1717F2Q35173889-85C7B4C7-2D6B-4466-B919-59A8B063EF43Q35208130-92C71B90-4BE7-406D-AE59-97D1964EAF63Q35316963-AA81FB99-3D3D-49C5-B274-3DF6B4694084Q35570857-2F7C90C6-8710-4383-A09D-8C217E78D38BQ35621042-BCA900C2-2176-4E5E-8FA7-6707150E3276Q35889850-D762B75B-03BD-4697-8EF9-5C77A4C86B5DQ35985180-9F621136-3524-48C3-A399-1D2A641CC78AQ36670498-AFB98A4A-6DF9-4DFF-AAF7-1BBBD61FC26CQ36790111-207A9495-EBDF-4600-899F-16B4B9D83A75Q37029649-B865BF5E-2A3E-4429-98F1-918044D1A6EEQ37106491-066D74AE-3AEA-406A-A94E-EC0D57F0573EQ37148870-DADB1864-A448-4AD3-B400-2EBA4D6A3FE6Q37170455-54A2F3B8-B3D3-4A1F-ABA5-98382647FB78Q37389775-1C2A89AC-4AEE-41FB-BA01-3732FA07CC0CQ37404594-3860DE93-0B05-4358-980B-5B8477905A59Q37406073-84C4F3F4-C235-459C-945B-2E61DB1A264CQ37498154-16CB01E0-3B2C-4733-91CF-A3FA021ACA56Q37578172-00165F54-EE3C-4CB9-9356-C520897733D2Q37690501-13BEEA90-7089-456B-80A3-B6556BF45FEBQ38770294-FF87F675-434B-45EC-9E0B-4B938F104703Q38853005-DD3E9F5A-8363-4041-A6DE-7AD38F7403F8Q41982613-779C56F4-1A8A-4C11-BA07-6476DEF47A43Q45010732-95A3157F-EA94-4978-9153-F13A5B1DBEFDQ48113845-8454A6BE-5387-4DAD-B943-F0CF42344412
P2860
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@ast
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@en
type
label
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@ast
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@en
prefLabel
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@ast
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@en
P2093
P2860
P356
P1433
P1476
Genetic testing for Alzheimer's disease and its impact on insurance purchasing behavior
@en
P2093
Cathleen D Zick
Charles J Mathews
J Scott Roberts
Robert J Pokorski
P2860
P304
P356
10.1377/HLTHAFF.24.2.483
P407
P577
2005-03-01T00:00:00Z